| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Dez―06 |
Virtual lab of artificial intelligence agents accelerating nanobody design against SARS-CoV-2 variants |
Hakjin Kim, Taeho Kwon, Sun-Uk Kim, Seon-Kyu Kim |
| 2 |
[GO] |
2025―Feb―21 |
Antibody-dependent enhancement of coronaviruses |
Tao Tao, Lili Tian, Jiayi Ke, Chuxie Zhang, Maochen Li, Xiaolong Xu, Junfen Fan, Yigang Tong, Huahao Fan |
| 3 |
[GO] |
2023―Okt―30 |
What we learned from lifting COVID-19 restrictions in Macao in December 2022 |
Chon Lok LEI, Hoi Man NG, Guihui QIN, Cheung Kwan YEUNG, Chon Leng LEI, Ren-He XU |
| 4 |
[GO] |
2023―Aug―09 |
Seeing the T cell Immunity of SARS-CoV-2 and SARS-CoV: Believing the Epitope-Oriented Vaccines |
Can Yue, Pengyan Wang, Jinmin Tian, George F. Gao, Kefang Liu, William J. Liu |
| 5 |
[GO] |
2023―Jun―05 |
TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses |
Jing-Xing Yang, Jen-Chih Tseng, Chih-Feng Tien, Chia-Yin Lee, Yi-Ling Liu, Jhe-Jhih Lin, Pei-Ju Tsai, Hung-Chun Liao, Shih-Jen Liu, Yu-Wen Su, Li-Chung Hsu, Jen-Kun Chen, Ming-Hsi Huang, Guann-Yi Yu, Tsung-Hsien Chuang |
| 6 |
[GO] |
2023―Mrz―13 |
Cardiovascular-related proteomic changes in ECFCs exposed to the serum of COVID-19 patients |
Lucía Beltrán-Camacho, Santosh D. Bhosale, Daniel Sánchez-Morillo, Ismael Sánchez-Gomar, Marta Rojas-Torres, Sara Eslava-Alcón, Mario Martínez-Torija, Mª Angeles Ruiz de Infante, Mª Dolores Nieto-Martín, Manuel A. Rodríguez-Iglesias, Juan A. Moreno, Esther Berrocoso, Martin R. Larsen, Rafael Moreno-Luna, Mª Carmen Durán-Ruiz |
| 7 |
[GO] |
2022―Sep―28 |
Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19 |
Man Wang, Wenguang Chang, Lei Zhang, Yuan Zhang |
| 8 |
[GO] |
2022―Sep―28 |
Humoral Immunogenicity to SARS-CoV-2 Vaccination in Liver Transplant Recipients: A Systematic Review and Meta-Analysis |
Jeong-Ju Yoo, Dong Keon Yon, Seung Won Lee, Jae Il Shin, Beom Kyung Kim |
| 9 |
[GO] |
2022―Sep―09 |
Traditional Chinese Medicine JingYinGuBiao Formula Therapy Improves the Negative Conversion Rate of SARS-CoV2 in Patients with Mild COVID-19 |
Bowu Chen, Peihua Geng, Jiaojiao Shen, Suthat Liangpunsakul, Hua Lyu, Jue Zhang, Yanbing Yang, Lei Zhang, Yuping Xu, Chunling Dong, Yanping Wang, Yan Xue, Wei Zhang, Hua Liu, Man Li, Yueqiu Gao |
| 10 |
[GO] |
2022―Sep―09 |
Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2 |
Limin Wang, Julián Candia, Lichun Ma, Yongmei Zhao, Luisa Imberti, Alessandra Sottini, Eugenia Quiros-Roldan, Kerry Dobbs, Peter D. Burbelo, Jeffrey I. Cohen, Ottavia M. Delmonte, Marshonna Forgues, Hui Liu, Helen F. Matthews, Elana Shaw, Michael A. Stack, Sarah E. Weber, Yu Zhang, Andrea Lisco, Irini Sereti, Helen C. Su, Luigi D. Notarangelo, Xin Wei Wang |
| 11 |
[GO] |
2022―Aug―26 |
COVID-19 prevention and control strategies: learning from the Macau model |
Yan-Jie Zhao, Jia-Qi Xu, Wei Bai, He-Li Sun, Bing Shui, Zhi-Xin Yang, Jingbo Huang, Robert D. Smith, Yuan-Jia Hu, Yu-Tao Xiang |
| 12 |
[GO] |
2022―Aug―12 |
Development and application of ribonucleic acid therapy strategies against COVID-19 |
Lin Ning, Mujiexin Liu, Yushu Gou, Yue Yang, Bifang He, Jian Huang |
| 13 |
[GO] |
2022―Jul―19 |
Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19 |
Weifeng He, Yuan Gao, Jing Zhou, Yi Shi, Dajing Xia, Han-Ming Shen |
| 14 |
[GO] |
2022―Jul―19 |
The global battle against SARS-CoV-2 and COVID-19 at the third year |
Chu-Xia Deng |
| 15 |
[GO] |
2022―Jul―19 |
The significance of advanced COVID-19 diagnostic testing in pandemic control measures |
Hang Fai Kwok |
| 16 |
[GO] |
2022―Jul―19 |
Effect of a Functional Phospholipid Metabolome-Protein Association Pathway on the Mechanism of COVID-19 Disease Progression |
Mingshan Xue, Teng Zhang, Zhangkai J. Cheng, Baojun Guo, Yifeng Zeng, Runpei Lin, Peiyan Zheng, Mingtao Liu, Fengyu Hu, Feng Li, Wensheng Zhang, Lu Li, Qi Zhao, Baoqing Sun, Xiaoping Tang |
| 17 |
[GO] |
2022―Jul―19 |
Interplay of LncRNAs NEAT1 and TUG1 in Incidence of Cytokine Storm in Appraisal of COVID-19 Infection |
Safaa I. Tayel, Eman A. El-Masry, Gehan A. Abdelaal, Somaia Shehab-Eldeen, Abdallah Essa, Nashwa M. Muharram |
| 18 |
[GO] |
2022―Jul―19 |
COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD |
Hanfei Chen, Qiang Chen |
| 19 |
[GO] |
2022―Jul―19 |
Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review |
Zhonghao Chen, Ying Zhang, Meng Wang, Md Sahidul Islam, Ping Liao, Yuanjia Hu, Xin Chen |
| 20 |
[GO] |
2022―Jul―19 |
Recipients of COVID-19 vaccines face challenges of SARS-CoV-2 variants |
Tianhong Li, Kathy Qian Luo |
| 21 |
[GO] |
2022―Jul―19 |
Structural basis of SARS-CoV-2 and its variants binding to intermediate horseshoe bat ACE2 |
Lingfeng Tang, Di Zhang, Pu Han, Xinrui Kang, Anqi Zheng, Zepeng Xu, Xin Zhao, Vivien Ya-Fan Wang, Jianxun Qi, Qihui Wang, Kefang Liu, George F. Gao |
| 22 |
[GO] |
2022―Jul―19 |
SARS-CoV-2 and the Nucleus |
Mengqi Chen, Yue Ma, Wakam Chang |
| 23 |
[GO] |
2022―Jul―19 |
Prospects of Coffee Leaf against SARS-CoV-2 Infection |
Chen-Shiou Wu, Hsiu-Mei Chiang, Yeh Chen, Chung-Yu Chen, Hsiao-Fan Chen, Wen-Chi Su, Wei-Jan Wang, Yu-Chi Chou, Wei-Chao Chang, Shao-Chun Wang, Mien-Chie Hung |
| 24 |
[GO] |
2022―Jul―19 |
Cross-variant protection against SARS-CoV-2 infection in hamsters immunized with monovalent and bivalent inactivated vaccines |
Zi-Wei Ye, Yilan Fan, Kaiming Tang, Chon Phin Ong, Cuiting Luo, Hon-Lam Chung, Tsun-Lam Leong, Ronghui Liang, Wai-Yin Lui, Runhong Zhou, Yun Cheng, Lu Lu, Pak-Hin Hinson Cheung, Jasper Fuk-Woo Chan, Zhiwei Chen, Kwok-Yung Yuen, Shuofeng Yuan, Kelvin Kai-Wang To, Dong-Yan Jin |
| 25 |
[GO] |
2022―Jul―19 |
Dysregulation of Innate and Adaptive Immune Responses in Asymptomatic SARS-CoV-2 Infection with Delayed Viral Clearance |
Shanshan Cao, Qing Zhang, Liu Song, Mingzhong Xiao, Yexing Chen, Dianbing Wang, Min Li, Jinchao Hu, Lin Lin, Ying Zheng, Kun Zhou, Shujian Ye, Juan Zhou, Ya Na Zhou, Jing Cui, Jingzhi Wang, Jing Sun, Junxiu Tao, Zhou Chen, Rong Chen, Peng Zhou, Zhengli Shi, Sheng Wei, Linhua Zhao, Hui Wang, Xiaoling Tong, Xiaodong Li, Dong Men, Baidong Hou, Xian-En Zhang |
| 26 |
[GO] |
2022―Jul―19 |
Signaling mechanisms of SARS-CoV-2 Nucleocapsid protein in viral infection, cell death and inflammation |
Wenbiao Wang, Junzhe Chen, Xueqing Yu, Hui-Yao Lan |
| 27 |
[GO] |
2022―Jul―19 |
Targeting ACLY efficiently inhibits SARS-CoV-2 replication |
Terrence Tsz-Tai Yuen, Jasper Fuk-Woo Chan, Bingpeng Yan, Cynthia Cheuk-Ying Shum, Yuanchen Liu, Huiping Shuai, Yuxin Hou, Xiner Huang, Bingjie Hu, Yue Chai, Chaemin Yoon, Tianrenzheng Zhu, Huan Liu, Jialu Shi, Jinjin Zhang, Jian-Piao Cai, Anna Jinxia Zhang, Jie Zhou, Feifei Yin, Shuofeng Yuan, Bao-Zhong Zhang, Hin Chu |
| 28 |
[GO] |
2022―Jul―19 |
Phosphatidic acid phosphatase 1 impairs SARS-CoV-2 replication by affecting the glycerophospholipid metabolism pathway |
Bingpeng Yan, Shuofeng Yuan, Jianli Cao, Kingchun Fung, Pok-Man Lai, Feifei Yin, Kong-Hung Sze, Zhenzhi Qin, Yubin Xie, Zi-Wei Ye, Terrence Tsz-Tai Yuen, Kenn Ka-Heng Chik, Jessica Oi-Ling Tsang, Zijiao Zou, Chris Chun-Yiu Chan, Cuiting Luo, Jian-Piao Cai, Kwok-Hung Chan, Tom Wai-Hing Chung, Anthony Raymond Tam, Hin Chu, Dong-Yan Jin, Ivan Fan-Ngai Hung, Kwok-Yung Yuen, Richard Yi-Tsun Kao, Jasper Fuk-Woo Chan |
| 29 |
[GO] |
2022―Jul―19 |
Long COVID and its Management |
Ho Cheng Koc, Jing Xiao, Weiwei Liu, Yong Li, Guokai Chen |
| 30 |
[GO] |
2022―Jul―19 |
Revealing the mystery of persistent smell loss in long COVID patients |
Jung Woo Park, Xiaoyan Wang, Ren-He Xu |
| 31 |
[GO] |
2022―Jun―14 |
Depressive symptoms and gender differences in older adults in Hong Kong during the COVID-19 pandemic: a network analysis approach |
Yu Jin, He-Li Sun, Simon Ching Lam, Zhaohui Su, Brian J. Hall, Teris Cheung, Ming-Zhao Qin, Chee H. Ng, Yu-Tao Xiang |
| 32 |
[GO] |
2022―Mai―04 |
Dynamic response landscape of immune cells identified immune dysfunction which predicts disease progression in COVID-19 infected patients |
Xiangyu Deng, Yao Zhang, Meiqi Li, Xiaolong Tang, Jing Shen, Yu Chen, Yueshui Zhao, Qinglian Wen, Xu Wu, Mingxing Li, Jing Li, Wenping Xu, Wanping Li, Zhangang Xiao, Deqiang Xian, Fukuan Du |
| 33 |
[GO] |
2022―Apr―08 |
Manifestations and Mechanism of SARS-CoV2 Mediated Cardiac Injury |
Si-chi Xu, Wei Wu, Shu-yang Zhang |
| 34 |
[GO] |
2022―Mrz―21 |
COVID-19 receptor and malignant cancers: Association of CTSL expression with susceptibility to SARS-CoV-2 |
Lianmei Zhang, Chunli Wei, Dabing Li, Jiayue He, Shuguang Liu, Haoyue Deng, Jingliang Cheng, Jiaman Du, Xiaoyan Liu, Hanchun Chen, Suan Sun, Hong Yu, Junjiang Fu |
| 35 |
[GO] |
2022―Feb―23 |
Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic |
Xianghui Li, Yabo Zhang, Libing He, Jiangzhe Si, Shuai Qiu, Yuhua He, Jiacun Wei, Zhili Wang, Longxiang Xie, Yanzhang Li, Tieshan Teng |
| 36 |
[GO] |
2022―Feb―23 |
B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies |
Yan Zhan, Hui Yin, Ji-Ye Yin |
| 37 |
[GO] |
2022―Feb―09 |
Virus-related Knowledge in Covid-19 Times - Results from two Cross-sectional Studies in Austria and Implications for School |
Marc Bracko, Uwe Karsten Simon |
| 38 |
[GO] |
2022―Jan―08 |
Human Organoids as a Promising Platform for Fighting COVID-19 |
Dong Chen, Xi Su, Haibo Chen, Siyan Chen, Yongsheng Zhao, Wei Wei |
| 39 |
[GO] |
2022―Jan―08 |
A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant |
Mengxin Zhang, Ying Liang, Dongsheng Yu, Bang Du, Weyland Cheng, Lifeng Li, Zhidan Yu, Shuying Luo, Yaodong Zhang, Huanmin Wang, Xianwei Zhang, Wancun Zhang |
| 40 |
[GO] |
2021―Dez―15 |
The COVID-19 infection in children and its association with the immune system, prenatal stress, and neurological complications |
Suliman Khan, Rabeea Siddique, Xiao Hao, Yueting Lin, Yuxin Liu, Xiaoyan Wang, Linlin Hua, Ghulam Nabi |
| 41 |
[GO] |
2021―Dez―15 |
Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy |
Yizhou Jiang, Limor Rubin, Tangming Peng, Linlin Liu, Xingan Xing, Philip Lazarovici, Wenhua Zheng |
| 42 |
[GO] |
2021―Dez―15 |
COVID-19: systemic pathology and its implications for therapy |
Qi Shen, Jie Li, Zhan Zhang, Shuang Guo, Qiuhong Wang, Xiaorui An, Haocai Chang |
| 43 |
[GO] |
2021―Okt―04 |
COVID-19 disease and malignant cancers: The impact for the furin gene expression in susceptibility to SARS-CoV-2 |
Dabing Li, Xiaoyan Liu, Lianmei Zhang, Jiayue He, Xianmao Chen, Shuguang Liu, Jiewen Fu, Shangyi Fu, Hanchun Chen, Junjiang Fu, Jingliang Cheng |
| 44 |
[GO] |
2021―Okt―04 |
The intraviral protein-protein interaction of SARS-CoV-2 reveals the key role of N protein in virus-like particle assembly |
Minghai Chen, Chuang Yan, Fujun Qin, Luping Zheng, Xian-En Zhang |
| 45 |
[GO] |
2021―Sep―06 |
Comprehensive landscape of the renin-angiotensin system in Pan-cancer: a potential downstream mediated mechanism of SARS-CoV-2 |
Yuqing Cui, Fengzhi Chen, Jiayi Gao, Mengxia Lei, Dandan Wang, Xiaoying Jin, Yan Guo, Liying Shan, Xuesong Chen |
| 46 |
[GO] |
2021―Sep―01 |
Gene Presence/Absence Variation analysis of coronavirus family displays its pan-genomic diversity |
Du Jiao, Xiaorui Dong, Yingyan Yu, Chaochun Wei |
| 47 |
[GO] |
2021―Sep―01 |
Receptor-binding domain of SARS-CoV-2 spike protein efficiently inhibits SARS-CoV-2 infection and attachment to mouse lung |
Hye Jin Shin, Keun Bon Ku, Hae Soo Kim, Hyun Woo Moon, Gi Uk Jeong, Insu Hwang, Gun Young Yoon, Sunhee Lee, Sumin Lee, Dae-Gyun Ahn, Kyun-Do Kim, Young-Chan Kwon, Bum-Tae Kim, Seong-Jun Kim, Chonsaeng Kim |
| 48 |
[GO] |
2021―Aug―06 |
RS-5645 attenuates inflammatory cytokine storm induced by SARS-CoV-2 spike protein and LPS by modulating pulmonary microbiota |
Te Liu, Jianchao Wu, Changpeng Han, Zhangbin Gong, Giuseppe La Regina, Jiulin Chen, Fangfang Dou, Romano Silvestri, Chuan Chen, Zhihua Yu |
| 49 |
[GO] |
2021―Jul―27 |
Inhibition of SARS-CoV-2 pseudovirus invasion by ACE2 protecting and Spike neutralizing peptides: An alternative approach to COVID19 prevention and therapy |
Jiang Chen, Song Li, Zhifeng Lei, Qinmin Tang, Ling Mo, Xing Zhao, Feifei Xie, Dan Zi, Jun Tan |
| 50 |
[GO] |
2021―Jul―27 |
Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2? |
Salvatore Santamaria |
| 51 |
[GO] |
2021―Jun―17 |
Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19 |
Fang Sun, Chenglin Mu, Hang Fai Kwok, Jiyuan Xu, Yingliang Wu, Wanhong Liu, Jean-Marc Sabatier, Cédric Annweiler, Xugang Li, Zhijian Cao, Yingqiu Xie |
| 52 |
[GO] |
2021―Jun―02 |
COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19 |
Yan Zhan, Xiang-Ping Li, Ji-Ye Yin |
| 53 |
[GO] |
2021―Jun―02 |
Inflammation characteristics and anti-inflammation treatment with tocilizumab of severe/critical COVID-19 patients: A retrospective cohort study |
Qin Hu, Yu Xu, Ying Xiang, Bin Wang, Zhiquan Yuan, Yifan Shan, Wenjing Zhang, Na Wu, Tingting Xia, Chengying Li, Weijia Xie, Xiaoyue Jia, Zubin Yu, Li Bai, Yafei Li |
| 54 |
[GO] |
2021―Mai―19 |
Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation |
Qian Tang, Yue Wang, Ling Ou, Jieling Li, Kai Zheng, Hui Zhan, Jiayu Gu, Guibao Zhou, Shouxia Xie, Jianping Zhang, Wei Huang, Shaoxiang Wang, Xiao Wang |
| 55 |
[GO] |
2021―Apr―12 |
The continued global battle against SARS-CoV-2 and COVID-19 |
Chu-Xia Deng |
| 56 |
[GO] |
2021―Apr―12 |
Development and application of therapeutic antibodies against COVID-19 |
Lin Ning, Hamza B. Abagna, Qianhu Jiang, Siqi Liu, Jian Huang |
| 57 |
[GO] |
2021―Apr―12 |
Developing effective siRNAs to reduce the expression of key viral genes of COVID-19 |
Renfei Wu, Kathy Qian Luo |
| 58 |
[GO] |
2021―Apr―12 |
Glucocorticoids are double-edged sword in the treatment of COVID-19 and cancers |
Ruixin Yang, Yingyan Yu |
| 59 |
[GO] |
2021―Apr―12 |
From impossible to possible: the lessons from the control of recent COVID-19 outbreaks in China |
Lixin Tai, Kengieng Wong, Li Wang, Li-jun Di |
| 60 |
[GO] |
2021―Apr―12 |
Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients |
Mingshan Xue, Teng Zhang, Hao Chen, Yifeng Zeng, Runpei Lin, Yingjie Zhen, Ning Li, Zhifeng Huang, Haisheng Hu, Luqian Zhou, Hui Wang, Xiaohua Douglas Zhang, Baoqing Sun |
| 61 |
[GO] |
2021―Apr―12 |
Review of Covid-19 vaccine clinical trials - A puzzle with missing pieces |
Hang Fai Kwok |
| 62 |
[GO] |
2021―Apr―12 |
Attitudes toward COVID-19 vaccines in Chinese college students |
Wei Bai, Hong Cai, Shou Liu, Huanzhong Liu, Han Qi, Xu Chen, Rui Liu, Teris Cheung, Zhaohui Su, Chee H. Ng, Yu-Tao Xiang |
| 63 |
[GO] |
2021―Apr―12 |
Artificial intelligence in the diagnosis of COVID-19: challenges and perspectives |
Shigao Huang, Jie Yang, Simon Fong, Qi Zhao |
| 64 |
[GO] |
2021―Apr―12 |
The role of CD4+FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment |
Yifei Wang, Jingbin Zheng, Md Sahidul Islam, Yang Yang, Yuanjia Hu, Xin Chen |
| 65 |
[GO] |
2021―Apr―12 |
Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery |
Yao Chen, Mei-Xiu Li, Guo-Dong Lu, Han-Ming Shen, Jing Zhou |
| 66 |
[GO] |
2021―Apr―12 |
mRNA vaccines for COVID-19: what, why and how |
Jung Woo Park, Philip N.P. Lagniton, Yu Liu, Ren-He Xu |
| 67 |
[GO] |
2021―Apr―12 |
Global landscape of patents related to human coronaviruses |
Kunmeng Liu, Zixuan Gu, Md Sahidul Islam, Thomas Scherngell, Xiangjun Kong, Jing Zhao, Xin Chen, Yuanjia Hu |
| 68 |
[GO] |
2021―Apr―12 |
In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor |
Lei Wen, Kaiming Tang, Kenn Ka-Heng Chik, Chris Chun-Yiu Chan, Jessica Oi-Ling Tsang, Ronghui Liang, Jianli Cao, Yaoqiang Huang, Cuiting Luo, Jian-Piao Cai, Zi-Wei Ye, Feifei Yin, Hin Chu, Dong-Yan Jin, Kwok-Yung Yuen, Shuofeng Yuan, Jasper Fuk-Woo Chan |
| 69 |
[GO] |
2021―Apr―12 |
SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3 |
Sin-Yee Fung, Kam-Leung Siu, Huayue Lin, Man Lung Yeung, Dong-Yan Jin |
| 70 |
[GO] |
2021―Apr―12 |
Construction and applications of SARS-CoV-2 pseudoviruses: a mini review |
Minghai Chen, Xian-En Zhang |
| 71 |
[GO] |
2021―Apr―12 |
SARS-CoV-2-induced Overexpression of miR-4485 Suppresses Osteogenic Differentiation and Impairs Fracture Healing |
Bobin Mi, Yuan Xiong, Chenming Zhang, Wu Zhou, Lang Chen, Faqi Cao, Fenghua Chen, Zhi Geng, Adriana C. Panayi, Yun Sun, Lin Wang, Guohui Liu |
| 72 |
[GO] |
2021―Apr―12 |
The Genetic Variant of SARS-CoV-2: Would it matter for Controlling the Devastating Pandemic? |
Shuxin Guo, Kefang Liu, Jun Zheng |
| 73 |
[GO] |
2021―Mrz―16 |
Should people with severe mental illness be prioritized for the COVID-19 vaccination? |
Yuan Yang, Wen Li, Qinge Zhang, Ling Zhang, Teris Cheung, Chee H Ng, Yu-Tao Xiang |
| 74 |
[GO] |
2021―Mrz―16 |
Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury |
Junzhe Chen, Wenbiao Wang, Ying Tang, Xiao-ru Huang, Xueqing Yu, Hui-Yao Lan |
| 75 |
[GO] |
2021―Mrz―16 |
Assessment of global asymptomatic SARS-CoV-2 infection and management practices from China |
Zheng Chen, Bili Wang, Shanshan Mao, Qing Ye |
| 76 |
[GO] |
2021―Feb―19 |
Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19 |
Jiewen Fu, Chunli Wei, Jiayue He, Lianmei Zhang, Ju Zhou, Kyathegowdanadoddi Srinivasa Balaji, Shiyi Shen, Jiangzhou Peng, Amrish Sharma, Junjiang Fu |
| 77 |
[GO] |
2021―Feb―19 |
Depression and its relationship with quality of life in frontline psychiatric clinicians during the COVID-19 pandemic in China: a national survey |
Hong-He Zhang, Yan-Jie Zhao, Chun Wang, Qinge Zhang, Hai-Yang Yu, Teris Cheung, Brian J. Hall, Feng-Rong An, Yu-Tao Xiang |
| 78 |
[GO] |
2021―Jan―31 |
A rapid screening classifier for diagnosing COVID-19 |
Yang Xia, Weixiang Chen, Hongyi Ren, Jianping Zhao, Lihua Wang, Rui Jin, Jiesen Zhou, Qiyuan Wang, Fugui Yan, Bin Zhang, Jian Lou, Shaobin Wang, Xiaomeng Li, Jie Zhou, Liming Xia, Cheng Jin, Jianjiang Feng, Wen Li, Huahao Shen |
| 79 |
[GO] |
2020―Nov―06 |
ACE2 Correlated With Immune Infiltration Serves As A Novel Prognostic Biomarker In Clear Cell Renal Cell Carcinoma: Implication For COVID-19 |
Wuping Yang, Lei Li, Kenan Zhang, Kaifang Ma, Haibiao Xie, Yanqing Gong, Jingcheng Zhou, Kan Gong |
| 80 |
[GO] |
2020―Nov―06 |
A Multiple-Hit Hypothesis Involving Reactive Oxygen Species and Myeloperoxidase Explains Clinical Deterioration and Fatality in COVID-19 |
Pravin T Goud, David Bai, Husam M Abu-Soud |
| 81 |
[GO] |
2020―Nov―06 |
Clinical characteristics and analysis of risk factors for disease progression of COVID-19: A retrospective Cohort Study |
Zhengtong Lv, Shubin Lv |
| 82 |
[GO] |
2020―Nov―06 |
Current advances in the development of SARS-CoV-2 vaccines |
Annoor Awadasseid, Yanling Wu, Yoshimasa Tanaka, Wen Zhang |
| 83 |
[GO] |
2020―Nov―06 |
SARS-CoV-2 variants evolved during the early stage of the pandemic and effects of mutations on adaptation in Wuhan populations |
Annoor Awadasseid, Yanling Wu, Yoshimasa Tanaka, Wen Zhang |
| 84 |
[GO] |
2020―Okt―09 |
Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients |
Yu-Jun Dai, Wei-Na Zhang, Wei-Da Wang, Si-Yuan He, Cheng-Cai Liang, Da-Wei Wang |
| 85 |
[GO] |
2020―Sep―25 |
Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19) |
Kalthoum Tizaoui, Ines Zidi, Keum Hwa Lee, Ramy Abou Ghayda, Sung Hwi Hong, Han Li, Lee Smith, Ai Koyanagi, Louis Jacob, Andreas Kronbichler, Jae Il Shin |
| 86 |
[GO] |
2020―Sep―11 |
Disease knowledge and attitudes during the COVID-19 epidemic among international migrants in China: a national cross-sectional study |
Cheng Wang, Qi Tian, Peizhen Zhao, Mingzhou Xiong, Carl A Latkin, Yiqun Gan, Brian J Hall, Bin Yang |
| 87 |
[GO] |
2020―Sep―08 |
The development of the 'COVID-19 Psychological Resilience Model' and its efficacy during the COVID-19 pandemic in China |
Zongling He, Jiajia Chen, Keliang Pan, Yuchuan Yue, Teris Cheung, Yin Yuan, Na Du, Yan Zhao, Yusu Feng, Die Zhou, You Zhou, Fengmei Lu, Yong Chen, Manxi He, Yu-Tao Xiang |
| 88 |
[GO] |
2020―Sep―08 |
COVID-19: Insight into the asymptomatic SARS-COV-2 infection and transmission |
Dongsheng Han, Rui Li, Yanxi Han, Rui Zhang, Jinming Li |
| 89 |
[GO] |
2020―Jul―24 |
Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients |
Xin Huang, Chaobin He, Xin Hua, Anna Kan, Shuxin Sun, Jun Wang, Shengping Li |
| 90 |
[GO] |
2020―Jul―24 |
Glucocorticoids save lives in COVID-19 patients |
Chu-Xia Deng |
| 91 |
[GO] |
2020―Jul―24 |
Immune Response and COVID-19: A mirror image of Sepsis |
Eduardo López-Collazo, José Avendaño-Ortiz, Alejandro Martín-Quirós, Luis A. Aguirre |
| 92 |
[GO] |
2020―Jul―02 |
Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels |
Zhen Xiang, Jialin Liu, Dake Shi, Wei Chen, Jun Li, Ranlin Yan, Yufang Bi, Weiguo Hu, Zhenggang Zhu, Yingyan Yu, Zhitao Yang |
| 93 |
[GO] |
2020―Jun―15 |
An overview of the expert consensus on the mental health treatment and services for major psychiatric disorders during COVID-19 outbreak: China's experiences |
Yu-Tao Xiang, Na Zhao, Yan-Jie Zhao, Zihan Liu, Qinge Zhang, Yuan Feng, Xiao-Na Yan, Teris Cheung, Chee H. Ng |
| 94 |
[GO] |
2020―Mai―03 |
A potential treatment of COVID-19 with TGF-β blockade |
WanJun Chen |
| 95 |
[GO] |
2020―Apr―11 |
Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China |
Annoor Awadasseid, Yanling Wu, Yoshimasa Tanaka, Wen Zhang |
| 96 |
[GO] |
2020―Mrz―21 |
The global battle against SARS-CoV-2 and COVID-19 |
Chu-Xia Deng |
| 97 |
[GO] |
2020―Mrz―21 |
Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 |
Naidi Yang, Han-Ming Shen |
| 98 |
[GO] |
2020―Mrz―21 |
Tribute to health workers in China: A group of respectable population during the outbreak of the COVID-19 |
Yu-Tao Xiang, Yu Jin, Yu Wang, Qinge Zhang, Ling Zhang, Teris Cheung |
| 99 |
[GO] |
2020―Mrz―21 |
Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey |
Bao-Liang Zhong, Wei Luo, Hai-Mei Li, Qian-Qian Zhang, Xiao-Ge Liu, Wen-Tian Li, Yi Li |
| 100 |
[GO] |
2020―Mrz―21 |
Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau |
Iek Long Lo, Chon Fu Lio, Hou Hon Cheong, Chin Ion Lei, Tak Hong Cheong, Xu Zhong, Yakun Tian, Nin Ngan Sin |
| 101 |
[GO] |
2020―Mrz―21 |
The COVID-19 outbreak and psychiatric hospitals in China: managing challenges through mental health service reform |
Yu-Tao Xiang, Yan-Jie Zhao, Zi-Han Liu, Xiao-Hong Li, Na Zhao, Teris Cheung, Chee H. Ng |
| 102 |
[GO] |
2020―Mrz―21 |
Progression of Mental Health Services during the COVID-19 Outbreak in China |
Wen Li, Yuan Yang, Zi-Han Liu, Yan-Jie Zhao, Qinge Zhang, Ling Zhang, Teris Cheung, Yu-Tao Xiang |
| 103 |
[GO] |
2020―Mrz―21 |
COVID-19: what has been learned and to be learned about the novel coronavirus disease |
Ye Yi, Philip N.P. Lagniton, Sen Ye, Enqin Li, Ren-He Xu |
| 104 |
[GO] |
2020―Mrz―21 |
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 |
Guangyu Zhou, Qi Zhao |
| 105 |
[GO] |
2020―Mrz―21 |
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective |
Yang Yang, Md Shahidul Islam, Jin Wang, Yuan Li, Xin Chen |
| 106 |
[GO] |
2020―Mrz―21 |
SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat |
Jun Zheng |
| 107 |
[GO] |
2020―Mrz―21 |
Zoonotic origins of human coronaviruses |
Zi-Wei Ye, Shuofeng Yuan, Kit-San Yuen, Sin-Yee Fung, Chi-Ping Chan, Dong-Yan Jin |
|
